Targeting Vasoactive Intestinal Peptidemediated Signaling Enhances Response To Immune Checkpoint Therapy In Pancreatic Ductal Adenocarcinoma

Ravindranathan, S., Passang, T., Li, J-M, Wang, S., Dhamsania, R., Ware, M.B., Zaidi, M.Y., Zhu, J., Cardenas, M., Liu, Y., Gumber, S., Robinson, B., Sen-Majumdar, A., Zhang, H., Chandrakasan, S., Kissick, H., Frey, A.B., Thomas, S.N., El-Rayes, B.F., Lesinski, G.B. & Waller, E.K. Targeting Vasoactive Intestinal Peptidemediated Signaling Enhances Response To Immune Checkpoint Therapy In Pancreatic Ductal Adenocarcinoma. Nature Communications. 2022, 13:6418. Oct-22.